Results 361 to 370 of about 72,862 (382)

Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.

Journal of Clinical Epidemiology, 1989
H. Buchwald, J. Matts, L. Fitch, R. Varco, G. S. Campbell, M. Pearce, A. Yellin, R. Smink, H. Sawin, C. Campos   +9 more
semanticscholar   +1 more source

Program on Surgical Control of the Hyperlipidemias (POSCH): recruitment experience.

Controlled Clinical Trials, 1987
H. Buchwald, J. Matts, B. J. Hansen, J. Long, L. Fitch   +4 more
semanticscholar   +1 more source

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

The Cochrane Library, 2014
Suetonia C Palmer, Jonathan C Craig, David W Johnson   +2 more
exaly  

Plasma lipoproteins and coronary arteriography in subjects in the program on the surgical control of the hyperlipidemias. Preliminary report.

Atherosclerosis, 1979
R. B. Moore, J. Long, J. Matts, K. Amplatz*, R. Varco, H. Buchwald   +5 more
semanticscholar   +1 more source

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

The Cochrane Library, 2009
Victor M Montori, Sean F Dinneen
exaly  

ALCOHOLIC HYPERLIPIDEMIA

Nutrition Reviews, 2009
openaire   +2 more sources

Autoimmune hyperlipidemia

Atherosclerosis, 1977
J L, Beaumont, V, Beaumont
openaire   +2 more sources

HMG CoA reductase inhibitors (statins) for dialysis patients

The Cochrane Library, 2014
Suetonia C Palmer, Jonathan C Craig, David W Johnson   +2 more
exaly  

Classification of the Hyperlipidemias

Annual Review of Medicine, 1977
openaire   +3 more sources

Evaluation of Lipid Peroxidation and Oxidative DNA Damage in Patients With Periodontitis and Hyperlipidemia

Journal of Periodontology, 2015
Zlem Fentoğlu, Justyna Ocha, Kamila Matyka   +2 more
exaly